Supply Chain

As part of its move to divest non-core assets, Johnson & Johnson is reportedly seeking buyers for its sterilization products division, according to Bloomberg.

David Rapp. Vice President of Supply Chain and CIO of Wheeling (W.Va.) Hospital. Mr. Rapp joined Wheeling Hospital in 2006 and currently serves as vice president of supply chain and CIO. He is responsible for supply chain direction and the hospital’s technology-based system,…

Novartis plans to auction off its generic pill business in the U.S. amid heightened competition, unnamed sources told Reuters Friday.

AstraZeneca's immunotherapy drug Imfinzi earned expanded approval to treat lung cancer Friday, reports Reuters.

Blood banks across the country, including those that supply blood to North Carolina hospitals, are seeing a decline in blood donations as a result of the widespread, severe flu outbreak, reports the The News & Observer.

Here are the seven latest drugs or medical devices approved by the FDA this week.

The FDA approved the first blood test in the U.S. to help physicians detect mild traumatic brain injury, or concussions, in adults.

The FDA sent a warning letter to Bayer Nov. 14 over various quality control issues at the drugmaker's headquarters in Leverkusen, Germany.

Janssen Pharmaceutical Co., a subsidiary of Johnson & Johnson, earned FDA approval Wednesday for its prostate cancer drug, Erleada.

A team of biochemistry, chemistry and mechanical engineering researchers at the University of Colorado Boulder developed a self-healing "electronic skin," or "e-skin," the university announced Feb. 9.